Healthcare: Pressemitteilungen - Kategorie - Seite 103

Healthcare

Category / Healthcare & Medical / Healthcare


New York Medical Malpractice Lawyers at Fitzgerald & Fitzgerald Win $3.15 Million Birth Injury Verdict

NEW YORK, NY: The New York Medical Malpractice Lawyers at Fitzgerald & Fitzgerald, URL http://www.lawfitz.com, Have Won a Jury Verdict of $3.15M in a Birth Injury Case ...

Home Instead Senior Care Receives ACHC Accreditation

MOUTAIN VIEW, CA: Certification Is Specific to Private Duty Posts ...

Preferred Medical Plan Announces Expansion Plans and Job Fair

CORAL GABLES, FL: Health Plan Expects to Significantly Expand Employment to Accommodate Expansion Initiatives ...

Lost... Confused... No Way Home...

TORONTO, ONTARIO: Canadian MedicAlert Foundation and the Alzheimer Society of Canada have joined forces to help bring people living with Alzheimer's disease and other dementias Safely Home ...

CONMED Corporation to Announce Second Quarter 2013 Financial Results on July 24, 2013

UTICA, NY: UTICA, NY -- (Marketwired) -- 07/10/13 -- CONMED Corporation (NASDAQ: CNMD) announced today that it expects to report second quarter 2013 financial results before the market opens on Wednesday, July ...

MDxHealth's Prostate Cancer Test Approved by New York State Department of Health

IRVINE, CA and LIEGE, BELGIUM: IRVINE, CA and LIEGE, BELGIUM -- (Marketwired) -- 07/10/13 -- MDxHealth SA (EURONEXT BRUSSELS: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to suppo ...

WaveTec Vision(R) Announces the Commercial Launch of VerifEye(TM) for the ORA System(R)

ALISO VIEJO, CA: Physicians Report LASIK-Like Results in Cataract Surgery With the Hardware Upgrade, Available Now ...

Nuvilex, Inc. Will Enter Phase III Trials With Advantages Using Cell Encapsulation

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 07/09/13 -- When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug if ...

uniQure Signs EU Commercialization Agreement With Chiesi Farmaceutici for First Approved Gene Therapy Treatment, and Announces EUR 45 Million (USD 58 Million) in Equity and Collaboration Financing

AMSTERDAM, THE NETHERLANDS: Partnership With Chiesi Farmaceutici for Commercialization of Glybera and Co-Development of Hemophilia B Gene Therapy in Europe and Certain Other Territories; Conversion of Outstanding Convertible Deb ...

Jack McMackin Joins Swinerton's Southern California Healthcare Team

IRVINE, CA: IRVINE, CA -- (Marketwired) -- 07/08/13 -- has selected Jack McMackin to further develop the company's position in the healthcare market for its Orange County and Los Angeles offices. In his ro ...

Implementation of Midwifery in New Brunswick Comes to a Halt

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 07/08/13 -- The Canadian Association of Midwives (CAM) is shocked to learn of the letter received by the Midwifery Council of New Brunswick stating that the prov ...

Arch Therapeutics Appoints Senior Management Team Members

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwired) -- 07/08/13 -- (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at controlling bleedin ...

How To Go Beyond Diabetes Symptoms

PO Box 50 Brandon, SD 57005: Did you know diabetes symptoms are caused from inflammation? ...

NeoMedigen Develops Anti-Aging Molecule RezGen5 for Obesity & Aging Skin

DEVONSHIRE, BERMUDA: DEVONSHIRE, BERMUDA -- (Marketwired) -- 07/08/13 -- NeoMedigen Limited, a public company traded on the Bermuda Stock Exchange Main Board under Ticker Symbol NEOM:BH (BERMUDA: NEOM) announced today ad ...

The Joint Commission Issues National Patient Safety Goal and Requirements for Medical Device Alarm Management

IRVINE, CA: Masimo SET(R) Measure-Through Motion and Low Perfusion Pulse Oximetry and Masimo Patient SafetyNet(TM) Shown to Help Clinicians Reduce False Alarms and Improve Patient Outcomes ...

Ablynx Starts Additional Phase I Studies With Anti-RSV Nanobody ALX-0171

GHENT, BELGIUM: GHENT, BELGIUM -- (Marketwired) -- 07/04/13 -- (EURONEXT BRUSSELS: ABLX) today announced that it has initiated two additional Phase I studies with its anti-RSV Nanobody®, ALX-0171, with the goal of ...

Nanobiotix Announces EUR 2.8 Million Grant From bpifrance to Accelerate Development of NBTXR3 in a Third New Indication

PARIS: Through ETPN (European Technology Platform of Nanomedicine), Nanobiotix Is Driving Nanomedicine in Europe and Is Now Involved in the First Nanomedicine Consortium in France With the launch of NICE Pro ...

Anapol Schwartz Attorney Obtained $2 Million Medical Malpractice Verdict

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 07/03/13 -- Anapol Schwartz attorney Lawrence R. Cohan obtained a $2 million verdict for the estate of a 25-year-old woman who died as a result of pneumonia misdi ...

Pyng Medical Corp. Announces Grant of Stock Options

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/02/13 -- Pyng Medical Corp. (TSX VENTURE: PYT) (the "Company") today announced that on July 1, 2013 it has granted a total of 145,000 opt ...

Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated

SUNRISE, FL: SUNRISE, FL -- (Marketwired) -- 07/02/13 -- Bioheart, Inc. (OTCQB: BHRT) announced today the successful enrollment and randomization of the first patient in the Phase III MIRROR Trial using MyoCell® ...


Seite 103 von 179:  « ..  102 103 104  105  106  107  108  109  110  111  .. » 179





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z